Bausch Health Companies | VRX - Trade Creditors


Bausch Health Companies reported $593M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Amgen USD 19.52B 1.37B Mar/2026
ANI Pharmaceuticals USD 69.69M 7.11M Mar/2026
Aurora Cannabis CAD 68.03M 18.68M Dec/2025
Bausch Health Companies USD 593M 7M Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Canopy Growth CAD 19.96M 1.83M Dec/2025
Corcept Therapeutics USD 33.31M 7.14M Mar/2026
Danaher USD 1.79B 54M Mar/2026
Drreddys Laboratories INR 454.04M 854K Dec/2025
Eli Lilly USD 5.03B 350M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Novo Nordisk DKK 14.8B 4.96B Mar/2026
Pacira USD 14.01M 1.14M Mar/2026
Perrigo USD 434.8M 39.7M Mar/2026
Phibro Animal Health USD 129.64M 3.65M Mar/2026
Prestige Brands USD 22.79M 20.15M Mar/2026
Supernus Pharmaceuticals USD 10.17M 97.63M Mar/2026
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026
Zoetis USD 507M 20M Mar/2026